Pneumacare Ltd
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
1 terminated/withdrawn out of 9 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Structured Light Plethysmography Against Standard of Care in the Diagnosis and Monitoring of Dysfunctional Breathing
Role: lead
SLP Model Development in the Diagnosis of COPD Patients
Role: lead
Structured Light Plethysmography in Obstructive Airways Disease
Role: collaborator
Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)
Role: collaborator
Validation of Structured Light Plethysmography: Asthma
Role: lead
Validation of Structured Light Plethysmography - Health and Disease
Role: lead
Validation of Structured Light Plethysmography
Role: lead
Pneumacare SLP Validation in Infants and in Clinical Bronchiolitis
Role: collaborator
Thora-3Di™ Respiratory Rate Validation
Role: lead
All 9 trials loaded